Scientists test if eczema drug repairs Skin's natural shield
NCT ID NCT05624112
Summary
This study looked at whether the medication dupilumab helps repair the skin's protective barrier in people with moderate-to-severe eczema. It involved 44 Chinese patients who received dupilumab for 16 weeks. Researchers measured how well the skin held moisture before and after gentle tape stripping to test its strength.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital)
Guangzhou, Guangdong, 510091, China
Conditions
Explore the condition pages connected to this study.